Literature DB >> 3007983

A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms.

M C Dalakas, G Elder, M Hallett, J Ravits, M Baker, N Papadopoulos, P Albrecht, J Sever.   

Abstract

A "post-polio" syndrome characterized by new neuromuscular symptoms, including muscle weakness, may develop years after recovery from acute paralytic poliomyelitis. We studied 27 patients (mean age, 50.6 years) in whom new muscle weakness developed a mean of 28.8 years after recovery from acute polio. We reevaluated these patients during a mean follow-up period of 8.2 years (range, 4.5 to 20) after they were originally studied at the National Institutes of Health. The total mean follow-up period after the onset of new weakness was 12.2 years (range, 6 to 29). The patients were assessed with quantitative muscle testing, muscle biopsy, electromyography, and virologic and immunologic examination of the cerebrospinal fluid. Muscle strength had declined in all patients. The rate of decline averaged 1 percent per year. The decrease was irregular, with subjective plateau periods that ranged from 1 to 10 years. None of the patients had amyotrophic lateral sclerosis. Oligoclonal bands (IgG) were found in the cerebrospinal fluid of 7 of 13 patients studied, but no specific elevation of antibodies to poliovirus was observed in the cerebrospinal fluid. The newly affected muscles that were evaluated longitudinally with follow-up muscle biopsies and electromyography showed signs of chronic and new denervation. Groups of atrophic muscle fibers (group atrophy) and "neurogenic jitter" were not present. New post-polio muscle weakness is not a life-threatening form of motor-neuron deterioration. It appears that this weakness is not due to a loss of whole motor neurons, as in amyotrophic lateral sclerosis, but that it is due to a dysfunction of the surviving motor neurons that causes a slow disintegration of the terminals of individual nerve axons.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007983     DOI: 10.1056/NEJM198604103141505

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  38 in total

1.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  Causes of neurogenic dysphagia.

Authors:  H S Kirshner
Journal:  Dysphagia       Date:  1989       Impact factor: 3.438

Review 3.  Poliomyelitis and the postpolio syndrome.

Authors:  Robin S Howard
Journal:  BMJ       Date:  2005-06-04

4.  Outcomes of Colorado children with acute flaccid myelitis at 1 year.

Authors:  Jan A Martin; Kevin Messacar; Michele L Yang; John A Maloney; Jennifer Lindwall; Terri Carry; Patricia Kenyon; Stefan H Sillau; Joyce Oleszek; Kenneth L Tyler; Samuel R Dominguez; Teri L Schreiner
Journal:  Neurology       Date:  2017-06-14       Impact factor: 9.910

Review 5.  Poliovirus and motor neuron disease.

Authors:  C N Martyn
Journal:  J Neurol       Date:  1990-10       Impact factor: 4.849

6.  The clinical measurement of swallowing in health and in neurogenic dysphagia.

Authors: 
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

Review 7.  Neurogenic dysphagia: what is the cause when the cause is not obvious?

Authors:  D W Buchholz
Journal:  Dysphagia       Date:  1994       Impact factor: 3.438

8.  Multiple sclerosis presenting as late functional deterioration after poliomyelitis.

Authors:  E Chroni; R S Howard; C P Panayiotopoulos; G T Spencer
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

9.  Evidence for transneuronal degeneration in the spinal cord in man: a quantitative investigation of neurons in the intermediate zone after long-term amputation of the unilateral upper arm.

Authors:  H Suzuki; K Oyanagi; H Takahashi; F Ikuta
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Update on current and emerging treatment options for post-polio syndrome.

Authors:  Elisabeth Farbu
Journal:  Ther Clin Risk Manag       Date:  2010-07-21       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.